BioCentury
ARTICLE | Company News

Lannett, UCB neurology, generics news

September 7, 2015 7:00 AM UTC

UCB is selling its U.S. generics subsidiary Kremers Urban Pharmaceuticals Inc. to Lannett for $1.2 billion in cash. UCB is also eligible for additional payments related to methylphenidate extended-rel...